EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Advances in Liquid Biopsy for Precision Oncology: Applications, Challenges, and Future Directions in Clinical Laboratories

Yaqiong Guo, Xueling Wei, Lin Zhu, Minghui Xiu

OncoTargets and Therapy · 2026-10 · Volume 19 · 1-21

DOI: 10.2147/ott.s649325 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift OncoTargets and Therapy, 2026-10. Verfasst von Yaqiong Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second People's Hospital of Gansu Province, Lanzhou, Gansu, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

MRDclinical laboratorycompanion diagnosticsctDNAliquid biopsymulti-omicsprecision oncology

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Second People's Hospital of Gansu Province, Lanzhou, Gansu, People's Republic of China.
  • Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, Gansu, People's Republic of China.

Zitieren

APA

Guo, Y., Wei, X., Zhu, L., & Xiu, M. (2026). Advances in Liquid Biopsy for Precision Oncology: Applications, Challenges, and Future Directions in Clinical Laboratories. OncoTargets and Therapy, Volume 19, 1-21. https://doi.org/10.2147/ott.s649325

Vancouver

Guo Y, Wei X, Zhu L, Xiu M. Advances in Liquid Biopsy for Precision Oncology: Applications, Challenges, and Future Directions in Clinical Laboratories. OncoTargets and Therapy. 2026;Volume 19:1-21. doi:10.2147/ott.s649325

BibTeX
@article{Guo2026,
  author = {Guo, Yaqiong and Wei, Xueling and Zhu, Lin and Xiu, Minghui},
  title = {Advances in Liquid Biopsy for Precision Oncology: Applications, Challenges, and Future Directions in Clinical Laboratories},
  journal = {OncoTargets and Therapy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--21},
  doi = {10.2147/ott.s649325}
}
Kostenlos starten →